SkyePharma AG: Clinical Trials

2 completed. 2 Phase 2.

By phase and status

Phase	Trials	Status
Phase 2	2	Completed 2

Follow SkyePharma AG: new trials by email

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Single-dose Crossover Study to Evaluate the Early Bronchodilating Effect of FlutiForm HFA pMDI in Adult Subjects With Mild to Moderate Asthma fluticasone propionate, formoterol fumarate - Mild to Moderate Asthma	Phase 2	Completed	SkyePharma AG	39	2008-09-01	2010-08-27
Single-dose Crossover Study to Compare the Safety and Efficacy of FlutiForm With Fluticasone and Formoterol Concurrently or Alone in Asthma Patients fluticasone propionate, formoterol fumarate - Asthma	Phase 2	Completed	SkyePharma AG	64	2004-10-01	2011-06-23

Conditions studied

Asthma (2)

Interventions

Fluticasone (2)  ·  Formoterol Fumarate (2)  ·  fluticasone-formoterol (2)

Countries

Ireland (1)  ·  United Kingdom (1)  ·  United States (1)